Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial (2019)
Stijn F.H. Raven, Christian J.P.A. Hoebe, Ann C.T.M. Vossen, Leo G. Vissere, Jeannine L.A. Hautvast, Anna H.E. Roukens, Jim E. van Steenbergen.
Artikel